- Home
- BBIO vs KMX Comparison
BBIO vs KMX Comparison
Compare BBIO & KMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- KMX
- Stock Information
- Founded
- BBIO 2015
- KMX 1993
- Country
- BBIO United States
- KMX United States
- Employees
- BBIO N/A
- KMX N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- KMX Retail-Auto Dealers and Gas Stations
- Sector
- BBIO Health Care
- KMX Consumer Discretionary
- Exchange
- BBIO Nasdaq
- KMX Nasdaq
- Market Cap
- BBIO 9.4B
- KMX 8.7B
- IPO Year
- BBIO 2019
- KMX 1997
- Fundamental
- Price
- BBIO $55.32
- KMX $44.37
- Analyst Decision
- BBIO Strong Buy
- KMX Buy
- Analyst Count
- BBIO 16
- KMX 15
- Target Price
- BBIO $64.44
- KMX $63.69
- AVG Volume (30 Days)
- BBIO 2.0M
- KMX 5.6M
- Earning Date
- BBIO 11-11-2025
- KMX 09-25-2025
- Dividend Yield
- BBIO N/A
- KMX N/A
- EPS Growth
- BBIO N/A
- KMX 28.08
- EPS
- BBIO N/A
- KMX 3.40
- Revenue
- BBIO $235,812,000.00
- KMX $28,279,819,000.00
- Revenue This Year
- BBIO $115.46
- KMX N/A
- Revenue Next Year
- BBIO $65.03
- KMX $2.06
- P/E Ratio
- BBIO N/A
- KMX $13.05
- Revenue Growth
- BBIO 7.62
- KMX 2.17
- 52 Week Low
- BBIO $21.72
- KMX $42.75
- 52 Week High
- BBIO $55.32
- KMX $91.25
- Technical
- Relative Strength Index (RSI)
- BBIO 59.91
- KMX 24.23
- Support Level
- BBIO $52.97
- KMX $44.19
- Resistance Level
- BBIO $55.13
- KMX $47.18
- Average True Range (ATR)
- BBIO 1.58
- KMX 1.58
- MACD
- BBIO 0.16
- KMX -0.63
- Stochastic Oscillator
- BBIO 84.41
- KMX 11.63
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About KMX CarMax Inc
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.